The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Human Cytochrome P450 1A1 Structure and Utility in Understanding Drug and Xenobiotic Metabolism
Open accessAbstract
Cytochrome P450 (CYP) 1A1 is an extrahepatic monooxygenase involved in the metabolism of endogenous substrates and drugs, as well as the activation of certain toxins and environmental pollutants. CYP1A1 is particularly well known for its ability to biotransform polycyclic aromatic hydrocarbons, such as benzo[a]pyrene in tobacco smoke, into carcinogens. CYP1A1 possesses functional similarities and differences with human CYP1A2 and CYP1B1 enzymes, but the structural basis for this has been unclear. We determined a 2.6 Å structure of human CYP1A1 with the inhibitor α-naphthoflavone. α-Naphthoflavone binds within an enclosed active site, with the planar benzochromen-4-one core packed flat against the I helix that composes one wall of the active site, and the 2-phenyl substituent oriented toward the catalytic heme iron. Comparisons with previously determined structures of the related cytochrome P450 1A2 and 1B1 enzymes reveal distinct features among the active sites that may underlie the functional variability of these enzymes. Finally, docking studies probed the ability of CYP1A structures to assist in understanding their known in vitro interactions with several typical substrates and inhibitors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Features and development of Coot
Emsley, P., Lohkamp, B., Scott, W. G., & Cowtan, K. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444910007493 · Cited by 29,915
The PyMOL Molecular Graphics System
DeLano, W. L. (2002) · Medical Entomology and Zoology · Cited by 18,147
The CCP4 suite: programs for protein crystallography
Collaborative Computational Project, N. 4. (1994) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444994003112 · Cited by 17,270
Kabsch, W., & Sander, C. (1983) · Biopolymers · doi:10.1002/bip.360221211 · Cited by 15,320
Refinement of Macromolecular Structures by the Maximum-Likelihood Method
Murshudov, G. N., Vagin, A. A., & Dodson, E. J. (1997) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444996012255 · Cited by 14,742
Needleman, S. B., & Wunsch, C. D. (1970) · Journal of Molecular Biology · doi:10.1016/0022-2836(70)90057-4 · Cited by 11,288
SWISS‐MODEL and the Swiss‐Pdb Viewer: An environment for comparative protein modeling
Guex, N., & Peitsch, M. C. (1997) · ELECTROPHORESIS · doi:10.1002/elps.1150181505 · Cited by 11,241
The Aryl Hydrocarbon Receptor Complex
Hankinson, O. (1995) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.35.040195.001515 · Cited by 1,649
The integration of macromolecular diffraction data
Leslie, A. G. W. (2006) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444905039107 · Cited by 1,341
Detection, delineation, measurement and display of cavities in macromolecular structures
Kleywegt, G. J., & Jones, T. A. (1994) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444993011333 · Cited by 969
Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1.
Shimada, T., Hayes, C. L., Yamazaki, H., Amin, S., Hecht, S. S., Guengerich, F. P., & Sutter, T. R. (1996) · PubMed · Cited by 895
Summary of information on human CYP enzymes: human P450 metabolism data
Rendic, S. (2002) · Drug Metabolism Reviews · doi:10.1081/dmr-120001392 · Cited by 820
Shimada, T., & Fujii‐Kuriyama, Y. (2004) · Cancer Science · doi:10.1111/j.1349-7006.2004.tb03162.x · Cited by 804
Integration of macromolecular diffraction data
Leslie, A. G. W. (2006) · International Tables for Crystallography · doi:10.1107/97809553602060000675 · Cited by 696
Environmental and chemical carcinogenesis
Wogan, G. N., Hecht, S. S., Felton, J. S., Conney, A. H., & Loeb, L. A. (2004) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2004.06.010 · Cited by 656
17 beta-estradiol hydroxylation catalyzed by human cytochrome P450 1B1.
Hayes, C. L., Spink, D. C., Spink, B. C., Cao, J. Q., Walker, N. J., & Sutter, T. R. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.18.9776 · Cited by 632
Shimada, T. (2006) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.21.257 · Cited by 606
Sansen, S., Yano, J. K., Reynald, R. L., Schoch, G. A., Griffin, K. J., Stout, C. D., & Johnson, E. F. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611692200 · Cited by 478
Cytochrome P450 CYP1A1: wider roles in cancer progression and prevention
Androutsopoulos, V. P., Tsatsakis, A. M., & Spandidos, D. A. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-187 · Cited by 476
Lee, A. J., Cai, M. X., Thomas, P. E., Conney, A. H., & Zhu, B. T. (2003) · Endocrinology · doi:10.1210/en.2003-0192 · Cited by 456
Metabolism of melatonin by human cytochromes p450
Ma, X., Idle, J. R., Krausz, K. W., & Gonzalez, F. J. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.002410 · Cited by 319
NISHIMURA, M., YAGUTI, H., YOSHITSUGU, H., NAITO, S., & SATOH, T. (2003) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.123.369 · Cited by 313
Bioflavonoids: selective substrates and inhibitors for cytochrome P450 CYP1A and CYP1B1
Doostdar, H., Burke, M. D., & Mayer, R. T. (2000) · Toxicology · doi:10.1016/s0300-483x(99)00215-2 · Cited by 284
Contributions of Human Enzymes in Carcinogen Metabolism
Rendic, S., & Guengerich, F. P. (2012) · Chemical Research in Toxicology · doi:10.1021/tx300132k · Cited by 279
CYTOCHROME P450 ACTIVATION OF ARYLAMINES AND HETEROCYCLIC AMINES
Kim, D., & Guengerich, F. P. (2005) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.100010 · Cited by 250
Resveratrol Is a Selective Human Cytochrome P450 1A1 Inhibitor
Chun, Y. J., Kim, M. Y., & Guengerich, F. P. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1152 · Cited by 243
Zhou, S.-F., Yang, L.-P., Zhou, Z.-W., Liu, Y.-H., & Chan, E. (2009) · The AAPS Journal · doi:10.1208/s12248-009-9127-y · Cited by 238
Shimada, T., Yun, C. H., Yamazaki, H., Gautier, J. C., Beaune, P. H., & Guengerich, F. P. (1992) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09132-1 · Cited by 235
Oxidation of Benzo[a]pyrene by Recombinant Human Cytochrome P450 Enzymes
Bauer, E., Guo, Z., Ueng, Y.-F., Bell, L. C., Zeldin, D., & Guengerich, F. P. (1995) · Chemical Research in Toxicology · doi:10.1021/tx00043a018 · Cited by 212
In utero tobacco exposure epigenetically modifies placental CYP1A1 expression
Suter, M., Abramovici, A., Showalter, L., Hu, M., Shope, C. D., Varner, M., & Aagaard-Tillery, K. (2010) · Metabolism · doi:10.1016/j.metabol.2010.01.013 · Cited by 188
Sandhu, P., Guo, Z. Y., Baba, T., Martin, M. V., Tukey, R. H., & Guengerich, F. P. (1994) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1994.1099 · Cited by 184
Cytochrome P450–dependent metabolism of ω-6 and ω-3 long-chain polyunsaturated fatty acids
Arnold, C., Konkel, A., Fischer, R., & Schunck, W.-H. (2010) · Pharmacological Reports · doi:10.1016/s1734-1140(10)70311-x · Cited by 174
Detection of cytochrome P450 gene expression in human placenta in first trimester of pregnancy
Hakkola, J., Raunio, H., Purkunen, R., Pelkonen, O., Saarikoski, S., Cresteil, T., & Pasanen, M. (1996) · Biochemical Pharmacology · doi:10.1016/0006-2952(96)00216-x · Cited by 174
Turesky, R. J., Constable, A., Richoz, J., Varga, N., Markovic, J., Martin, M. V., & Guengerich, F. P. (1998) · Chemical Research in Toxicology · doi:10.1021/tx980022n · Cited by 170
Structural Characterization of the Complex between α-Naphthoflavone and Human Cytochrome P450 1B1
Wang, A., Savas, U., Stout, C. D., & Johnson, E. F. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.204420 · Cited by 169
Expression of cytochromes P450 1A1 and 1B1 in human lung from smokers, non-smokers, and ex-smokers
KIM, J. (2004) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2003.11.015 · Cited by 166
Oxidation of xenobiotics by recombinant human cytochrome P450 1B1.
Shimada, T., Gillam, E. M. J., Sutter, T. R., Strickland, P. T., Guengerich, F. P., & Yamazaki, H. (1997) · PubMed · Cited by 166
Schwarz, D., Kisselev, P., Ericksen, S. S., Szklarz, G. D., Chernogolov, A. A., Honeck, H., Schunck, W., & Roots, I. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2003.12.023 · Cited by 144
Self-citationPiver, B., Fer, M., Vitrac, X., Mérillon, J., Dréano, Y., Berthou, F., & Lucas, D. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.05.008 · Cited by 136
Mast, N., White, M. A., Bjorkhem, I., Johnson, E. F., Stout, C. D., & Pikuleva, I. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803717105 · Cited by 133
Reid, J. M., Kuffel, M. J., Miller, J. K., Ríos, R., & Ames, M. M. (1999) · PubMed · Cited by 133
Willey, J. C., Coy, E. L., Frampton, M. W., Torres, A., Apostolakos, M. J., Hoehn, G., Schuermann, W. H., Thilly, W. G., Olson, D. E., Hammersley, J. R., et al. (1997) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.17.1.2783 · Cited by 133
Shimada, T., Tanaka, K., Takenaka, S., Murayama, N., Martin, M. V., Foroozesh, M. K., Yamazaki, H., Guengerich, F. P., & Komori, M. (2010) · Chemical Research in Toxicology · doi:10.1021/tx100286d · Cited by 129
Hammons, G. (1997) · Carcinogenesis · doi:10.1093/carcin/18.4.851 · Cited by 126
Leong, C.-O., Gaskell, M., Martin, E. A., Heydon, R. T., Farmer, P. B., Bibby, M. C., Cooper, P. A., Double, J. A., Bradshaw, T. D., & Stevens, M. F. G. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600719 · Cited by 114
Quantitation of cytochrome P450 mRNA levels in human skin
Yengi, L. G., Xiang, Q., Pan, J., Scatina, J., Kao, J., Ball, S. E., Fruncillo, R. J., Ferron‐Brady, G., & Wolf, C. R. (2003) · Analytical Biochemistry · doi:10.1016/s0003-2697(03)00042-3 · Cited by 101
Recombinant Human Cytochrome P450 1B1 Expression inEscherichia coli
Shimada, T., Wunsch, R. M., Hanna, I. H., Sutter, T. R., Guengerich, F. P., & Gillam, E. M. J. (1998) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1998.0808 · Cited by 91
Mechanism-based inhibition of human cytochrome P450 1A1 by rhapontigenin.
Chun, Y., Ryu, S. Y., Jeong, T. C., & Kim, M. Y. (2001) · PubMed · Cited by 85
Flavonoids inhibit genetic toxicity produced by carcinogens in cells expressing CYP1A2 and CYP1A1
Lautraite, S., Musonda, A. C., Doehmer, J., Edwards, G. O., & Chipman, J. K. (2002) · Mutagenesis · doi:10.1093/mutage/17.1.45 · Cited by 84
van de Kerkhof, E. G., de Graaf, I. A. M., Ungell, A.-L. B., & Groothuis, G. M. M. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.018820 · Cited by 82
Szklarz, G. D., & Paulsen, M. D. (2002) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2002.10506831 · Cited by 53
Self-citationZhao, Y., Sun, L., Muralidhara, B. K., et al. (2007) · Biochemistry · doi:10.1021/bi7011614 · Cited by 44
Key Residues Controlling Binding of Diverse Ligands to Human Cytochrome P450 2A Enzymes
DeVore, N. M., Smith, B. D., Wang, J. L., Lushington, G. H., & Scott, E. E. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.109.026765 · Cited by 40
Self-citationFunctional role of residues in the helix B′ region of cytochrome P450 2B1
Honma, W., Li, W., Liu, H. S., Scott, E. E., & Halpert, J. R. (2004) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2004.12.014 · Cited by 36
Self-citationIba, M. M., Shin, M., & Caccavale, R. J. (2010) · Toxicology · doi:10.1016/j.tox.2010.04.012 · Cited by 12
Cited by
Polycyclic Aromatic Hydrocarbons: From Metabolism to Lung Cancer
Moorthy, B., Chu, C., & Carlin, D. J. (2015) · Toxicological Sciences · doi:10.1093/toxsci/kfv040 · Cited by 801
Exposure to polycyclic aromatic hydrocarbons with special focus on cancer
Rengarajan, T., Rajendran, P., Nandakumar, N., Lokeshkumar, B., Rajendran, P., & Nishigaki, I. (2015) · Asian Pacific Journal of Tropical Biomedicine · doi:10.1016/s2221-1691(15)30003-4 · Cited by 602
Recent Structural Insights into Cytochrome P450 Function
Guengerich, F. P., Waterman, M. R., & Egli, M. (2016) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2016.05.006 · Cited by 383
Barnes, J. L., Zubair, M., John, K., Poirier, M. C., & Martin, F. L. (2018) · Biochemical Society Transactions · doi:10.1042/bst20180519 · Cited by 318
Metadata
- Authors
- Walsh, A. A., Szklarz, G. D., & Scott, E. E.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2013-05
- Volume
- 288
- Issue
- 18
- Pages
- 12932-12943
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1999060084
- Cited by
- 283
- References
- 55
- FWCI
- 21.92
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.